Lincoln Pharmaceuticals Limited
NSE:LINCOLN.NS
727.5 (INR) • At close September 19, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Omzet
| 5,805.496 | 5,103.088 | 4,681.974 | 4,147.479 | 3,768.406 | 3,569.195 | 3,549.997 | 3,606.426 | 4,001.504 | 2,660.745 | 2,112.669 | 1,928.787 | 1,754.566 | 1,826.866 | 1,267.284 | 1,144.412 | 862.319 |
| Kosten van de omzet
| 3,918.63 | 2,413.969 | 2,197.872 | 1,988.822 | 1,837.471 | 1,764.792 | 1,935.978 | 2,371.769 | 2,959.257 | 1,909.816 | 1,463.287 | 1,323.614 | 1,172.239 | 1,277.466 | 783.691 | 1,047.83 | 768.634 |
| Brutowinst
| 1,886.866 | 2,689.119 | 2,484.102 | 2,158.657 | 1,930.935 | 1,804.403 | 1,614.018 | 1,234.657 | 1,042.247 | 750.928 | 649.383 | 605.174 | 582.326 | 549.4 | 483.592 | 96.582 | 93.685 |
| Brutowinstmarge
| 0.325 | 0.527 | 0.531 | 0.52 | 0.512 | 0.506 | 0.455 | 0.342 | 0.26 | 0.282 | 0.307 | 0.314 | 0.332 | 0.301 | 0.382 | 0.084 | 0.109 |
| Onderzoek- en ontwikkelingskosten
| 0 | 117.691 | 0 | 93.632 | 82.996 | 89.383 | 70.916 | 52.979 | 55.88 | 45.995 | 30.964 | 30.018 | 0 | 0 | 0 | 0 | 0 |
| Algemene en administratieve kosten
| 0 | 933.297 | 178.192 | 138.246 | 113.673 | 107.176 | 75.867 | 26.834 | 130.755 | 95.639 | 61.07 | 65.794 | 80.563 | 80.713 | 73.683 | 0 | 0 |
| Verkoop- en marketingkosten
| 0 | 48.085 | 251.542 | 229.117 | 244.128 | 177.372 | 187.632 | 248.817 | 217.874 | 220.524 | 190.325 | 210.426 | 205.753 | 224.649 | 187.008 | 0 | 0 |
| Verkoop-, algemene en administratieve kosten
| 994.016 | 981.382 | 429.734 | 367.363 | 357.801 | 284.548 | 263.499 | 275.651 | 348.629 | 316.163 | 251.395 | 276.22 | 286.315 | 305.362 | 260.691 | 0 | 0 |
| Overige kosten
| 344.225 | 224.729 | 99.977 | 56.639 | 0.011 | 0.16 | 3.001 | 536.983 | 330.821 | 209.43 | 218.132 | 181.619 | 175.663 | 129.885 | 115.025 | 5.956 | 6.813 |
| Bedrijfskosten
| 994.016 | 1,888.749 | 1,600.167 | 1,361.945 | 1,323.126 | 1,190.06 | 1,139.75 | 812.634 | 679.451 | 525.593 | 469.527 | 457.838 | 461.978 | 435.247 | 375.716 | 5.956 | 6.813 |
| Bedrijfsresultaat
| 892.85 | 805.469 | 876.979 | 798.009 | 583.389 | 608.204 | 474.268 | 422.023 | 362.796 | 225.335 | 179.855 | 147.335 | 120.348 | 114.153 | 107.877 | 90.626 | 86.872 |
| Bedrijfsresultaat ratio
| 0.154 | 0.158 | 0.187 | 0.192 | 0.155 | 0.17 | 0.134 | 0.117 | 0.091 | 0.085 | 0.085 | 0.076 | 0.069 | 0.062 | 0.085 | 0.079 | 0.101 |
| Totaal overige inkomsten en kosten netto
| 329.576 | 199.329 | 82.414 | 39.199 | 88.937 | 13.742 | -11.798 | -53.592 | -32.141 | -26.878 | -59.142 | -33.496 | -46.465 | -31.798 | -22.04 | -19.944 | -21.67 |
| Inkomen voor belasting
| 1,222.426 | 1,004.798 | 959.394 | 837.205 | 672.324 | 621.945 | 462.471 | 368.43 | 330.655 | 198.457 | 120.713 | 113.84 | 73.883 | 82.355 | 85.837 | 70.682 | 65.202 |
| Inkomen voor belasting ratio
| 0.211 | 0.197 | 0.205 | 0.202 | 0.178 | 0.174 | 0.13 | 0.102 | 0.083 | 0.075 | 0.057 | 0.059 | 0.042 | 0.045 | 0.068 | 0.062 | 0.076 |
| Belastingkosten
| 289.377 | 275.805 | 265.843 | 214.708 | 157.661 | 134.557 | 115.977 | 97.54 | 92.658 | 48.043 | 18.867 | 18.497 | 22.603 | 23.857 | 24.793 | 0 | 18.576 |
| Nettowinst
| 933.049 | 728.993 | 693.55 | 622.501 | 514.394 | 487.101 | 346.23 | 270.648 | 236.823 | 150.121 | 106.543 | 96.623 | 51.188 | 41.664 | 61.043 | 70.682 | 46.626 |
| Nettowinstmarge
| 0.161 | 0.143 | 0.148 | 0.15 | 0.137 | 0.136 | 0.098 | 0.075 | 0.059 | 0.056 | 0.05 | 0.05 | 0.029 | 0.023 | 0.048 | 0.062 | 0.054 |
| WPA (Winst Per Aandeel)
| 46.58 | 36.4 | 34.63 | 31.08 | 25.72 | 24.36 | 17.31 | 15.73 | 14.52 | 9.2 | 6.53 | 5.92 | 3.14 | 3.02 | 6.71 | 5.72 | 6.13 |
| Verwaterde WPA
| 46.58 | 36.4 | 34.63 | 31.08 | 25.72 | 24.36 | 17.31 | 15.73 | 14.16 | 9.2 | 6.53 | 5.92 | 3.14 | 3.02 | 6.71 | 5.72 | 6.13 |
| EBITDA
| 999.097 | 1,116.76 | 1,020.899 | 895.631 | 768.314 | 717.818 | 570.32 | 491.787 | 453.363 | 317.709 | 215.346 | 155.996 | 122.408 | 130.821 | 119.482 | 99.253 | 93.939 |
| EBITDA ratio
| 0.172 | 0.219 | 0.218 | 0.216 | 0.204 | 0.201 | 0.161 | 0.136 | 0.113 | 0.119 | 0.102 | 0.081 | 0.07 | 0.072 | 0.094 | 0.087 | 0.109 |